Leading technology and continued investment enable us to address global development needs throughout the product life cycle — from Phase I Clinical trials through commercialization and ongoing supply
PCI Pharma Services has announced closing of majority stake acquisition by Kohlberg and Mubadala. (Credit: Adam Radosavljevic from Pixabay)
Mubadala Investment Company and Partners Group (acting on behalf of its clients) will have minority shares in the Company.
This milestone is a key step for PCI, as KohIberg and Mubadala will be partnering with PCl’s management team, led by CEO Salim Haffar, to continue the Company’s transformation journey by adding specific capabilities and geographies organically and inorganically in order to improve PCI’s customer experience and enable its customers to bring life-changing biopharmaceutical therapies to market.
Leveraging the global growth trends in biologics and specialized drug therapies, future capabilities include sterile fill finish of injectables, expanding high potency and specialized manufacturing, and further geographic expansion into Asia and greater Europe.
Kohlberg is a leading private equity firm headquartered in Mount Kisco, N.Y. with over 30 years of successful experience partnering with management and companies like PCI Pharma Services. Mubadala Investment Company (“Mubadala”), is a sovereign investor managing a global portfolio, aimed at generating sustainable financial returns for its shareholder, the Government of Abu Dhabi.
The global healthcare industry trusts PCI for the drug development solutions that increase their products’ speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches each year and over five decades in the healthcare services business.
Leading technology and continued investment enable us to address global development needs throughout the product life cycle — from Phase I Clinical trials through commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patients’ lives.
Kohlberg & Company, LLC (“Kohlberg”) is a leading private equity firm headquartered in Mount Kisco, New York. Since its inception in 1987, Kohlberg has organized nine private equity funds, through which it has raised over $10 billion of committed equity capital. Over its 33-year history, Kohlberg has completed 82 platform investments and approximately 200 add-on acquisitions, with an aggregate transaction value in excess of $25 billion.
Source: Company Press Release